Evelyne Polack

Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals

Michael W. Leach, Wendy Halpern, Carol W. Johnson et al. · Toxicologic Pathology · 2010 · 98 citations

Tissue Cross-reactivity, Immunocytochemical Technique, Immunology +19

Sustained hepatic expression of FoxM1B in transgenic mice has minimal effects on hepatocellular carcinoma development but increases cell proliferation rates in preneoplastic and early neoplastic lesions

Olga A. Kalinina, Sergey Kalinin, Evelyne Polack et al. · Oncogene · 2003 · 56 citations

Hepatology, Oncogenic Agent, Medicine +12

Concentrations of trace minerals in the spinal cord of horses with equine motor neuron disease

Evelyne Polack, John Μ. King, J. F. Cummings et al. · American Journal of Veterinary Research · 2000 · 39 citations · Full text

Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases

Bin Ma, Tonika Bohnert, Kevin L. Otipoby et al. · Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis

Brian T. Hopkins, Eris Bame, Bekim Bajrami et al. · Journal of Medicinal Chemistry · 2021 · 36 citations · Full text

Immunology, Neurological Progress, Immunotherapy +16